TRANSLARNA Trademark

Trademark Overview

On Thursday, February 17, 2022, a trademark application was filed for TRANSLARNA with the United States Patent and Trademark Office. The USPTO has given the TRANSLARNA trademark a serial number of 97272353. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Monday, October 6, 2025. This trademark is owned by PTC Therapeutics, Inc.. The TRANSLARNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic disorders
translarna

General Information

Serial Number97272353
Word MarkTRANSLARNA
Filing DateThursday, February 17, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateMonday, October 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Description of MarkThe mark consists of the word "translarna" in stylized letters with a spiral-like design composed of three partial concentic black semicircles each of which is wider at one end and tapers toward the other end with a solid circle in the middle of the spiral-like design, the design being placed partially above the last "a" in the word "translarna" and extending beyond and partially down next to the word "translarna".
Goods and ServicesPharmaceutical preparations for the treatment of genetic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateThursday, November 16, 2023
First Use In Commerce DateThursday, November 16, 2023

Trademark Owner History

Party NamePTC Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NamePTC Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Monday, February 21, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Tuesday, June 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 9, 2023SOU EXTENSION 1 FILED
Thursday, February 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 1, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 3, 2023ASSIGNED TO EXAMINER
Friday, August 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2023SOU EXTENSION 2 FILED
Friday, August 11, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 15, 2024SOU EXTENSION 3 FILED
Thursday, February 15, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 7, 2025SOU EXTENSION 5 GRANTED
Monday, July 7, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU EXTENSION 4 GRANTED
Monday, September 9, 2024SOU EXTENSION 4 FILED
Sunday, March 9, 2025SOU EXTENSION 5 FILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 15, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, October 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 6, 2025NON-FINAL ACTION E-MAILED
Monday, October 6, 2025SU - NON-FINAL ACTION - WRITTEN
Friday, September 12, 2025TEAS STATEMENT OF USE RECEIVED
Friday, September 12, 2025USE AMENDMENT FILED

Related Keywords

translarna disorders genetic treatment preparations pharmaceutical